Revenue from Contracts with Customers

9 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 1 to our consolidated financial statements in Item 8 of the 2021 Annual Report on Form 10-K.

Disaggregation of Revenue

Our revenue is disaggregated based on reporting segment, product category and geographical region. We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (“OEM”). Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three and nine-month periods ended September 30, 2022 and 2021 (in thousands):

	Three Months Ended						Three Months Ended
	September 30, 2022						September 30, 2021
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	67,200	$	43,498	$	110,698	$	61,282	$	39,777	$	101,059
Cardiac Intervention		33,194		53,654		86,848		30,562		49,251		79,813
Custom Procedural Solutions		27,078		18,614		45,692		27,895		21,540		49,435
OEM		29,425		6,286		35,711		25,025		4,372		29,397
Total		156,897		122,052		278,949		144,764		114,940		259,704
Endoscopy
Endoscopy Devices		7,674		552		8,226		6,741		576		7,317
Total	$	164,571	$	122,604	$	287,175	$	151,505	$	115,516	$	267,021

	Nine Months Ended						Nine Months Ended
	September 30, 2022						September 30, 2021
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	195,095	$	132,331	$	327,426	$	181,383	$	118,190	$	299,573
Cardiac Intervention		95,652		162,257		257,909		93,030		147,173		240,203
Custom Procedural Solutions		80,951		60,096		141,047		80,179		63,313		143,492
OEM		87,269		18,904		106,173		75,335		14,399		89,734
Total		458,967		373,588		832,555		429,927		343,075		773,002
Endoscopy
Endoscopy Devices		23,270		1,741		25,011		21,721		1,536		23,257
Total	$	482,237	$	375,329	$	857,566	$	451,648	$	344,611	$	796,259